Company Filing History:
2 out of 591 
2 out of 1,235 Years Active: 2012
Title: Takahide Kohro: Innovator in Nuclear Transfer Promoters
Introduction
Takahide Kohro is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of nuclear transfer promoters for proteins involved in cellular processes. With a total of two patents to his name, Kohro's work has the potential to impact medical treatments and pharmaceutical compositions.
Latest Patents
Kohro's latest patents include a nuclear transfer promoter for Rac protein and a method of screening the same. This invention comprises an isoprenoid synthesis inhibitor and/or a geranylgeranyl transferase inhibitor, such as an HMG-CoA synthase inhibitor, an HMG-CoA reductase inhibitor, an AMPK activator, or a farnesyl pyrophosphoric acid synthase preparation. The patent also details a blood vessel remedy that utilizes this nuclear transfer promoter as the active ingredient, along with a method for screening the remedy by assessing the ability of Rac protein to transfer into the nucleus.
Additionally, he has developed a method for screening pharmaceutical compositions that promote the nuclear transfer of Cdc42 protein. This patent similarly includes a nuclear transfer promoter for Cdc42 protein, comprising the same types of inhibitors and detailing its use in blood vessel remedies.
Career Highlights
Throughout his career, Takahide Kohro has worked with notable companies such as Kowa Company Limited and Nissan Chemical Industries Limited. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Kohro has collaborated with esteemed colleagues, including Yoshikazu Shibasaki and Takao Hamakubo. These partnerships have likely enhanced his research and development efforts, leading to his innovative patents.
Conclusion
Takahide Kohro is a distinguished inventor whose work in nuclear transfer promoters has the potential to advance medical science. His contributions reflect a commitment to innovation and collaboration in the field of biotechnology.